Replies to post #23252 on Cytodyn Inc (CYDY)

[finesand]

bucks- they slowly start covering it, thx

first only copy & paste of the PR, as usual.

The in depth CD02 ASM coverage on natap.org yesterday was the first with impact, now a little write-up in medpagetoday.com.
Let's see how it goes .. slow promotion in the sector (o8>

[Northstar42]

Thanks for posting the two articles. Each article should be featured and/or referenced in the Offering Memorandum which is distributed to prospective buyers, as they represent independent perspectives on PRO 140.

[trding]

In addition, he said, the company has a meeting scheduled with the FDA later this month to discuss the product license application summation, where this research and the safety data will be presented. After that, Dhody said, the plan is to determine the submission strategy.

[rab1]

What should we infer by the preceding paragraph which references 32 adverse events?